PH24225A - Medicaments in sustained release unit dose form - Google Patents

Medicaments in sustained release unit dose form

Info

Publication number
PH24225A
PH24225A PH32344A PH32344A PH24225A PH 24225 A PH24225 A PH 24225A PH 32344 A PH32344 A PH 32344A PH 32344 A PH32344 A PH 32344A PH 24225 A PH24225 A PH 24225A
Authority
PH
Philippines
Prior art keywords
sustained release
medicament
release unit
coating
medicaments
Prior art date
Application number
PH32344A
Other languages
English (en)
Inventor
Paul Jonathan Harrison
John Richard Langridge
Christopher John Potter
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of PH24225A publication Critical patent/PH24225A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
PH32344A 1984-06-04 1985-05-31 Medicaments in sustained release unit dose form PH24225A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form

Publications (1)

Publication Number Publication Date
PH24225A true PH24225A (en) 1990-04-10

Family

ID=10561912

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32344A PH24225A (en) 1984-06-04 1985-05-31 Medicaments in sustained release unit dose form

Country Status (20)

Country Link
US (1) US4806361A (de)
EP (1) EP0164959B1 (de)
JP (1) JPS611614A (de)
KR (1) KR920004094B1 (de)
AT (1) ATE73323T1 (de)
AU (1) AU573006B2 (de)
CA (1) CA1258232A (de)
DE (1) DE3585560D1 (de)
DK (1) DK164259C (de)
ES (1) ES8608863A1 (de)
FI (1) FI87990C (de)
GB (1) GB8414220D0 (de)
GR (1) GR851356B (de)
IL (1) IL75403A (de)
MX (1) MX159928A (de)
NO (1) NO166063C (de)
NZ (1) NZ212268A (de)
PH (1) PH24225A (de)
PT (1) PT80583B (de)
ZA (1) ZA854116B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862314A (ja) * 1981-10-07 1983-04-13 Mazda Motor Corp 過給機付エンジンの吸気装置
JPS5993939A (ja) * 1982-11-19 1984-05-30 Toyota Motor Corp 内燃機関のノツキング制御装置
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA2007055A1 (en) * 1989-01-06 1990-07-06 Garth Boehm Theophylline dosage form
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions
JPH05149118A (ja) * 1991-11-29 1993-06-15 Mitsubishi Motors Corp エンジンの圧縮比を変化させる方法
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
EP0869847B1 (de) 1995-05-09 2003-03-05 Phoqus Limited Elektrostatische beschichtung
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
JP2003508422A (ja) 1999-09-02 2003-03-04 ノストラム・ファーマスーティカルズ・インコーポレイテッド 放出制御ペレット製剤
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
JP2002003366A (ja) * 2000-06-23 2002-01-09 Freunt Ind Co Ltd 固形薬剤用水系コーティング剤組成物
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
EP2161036B1 (de) * 2007-06-06 2014-12-10 Asahi Kasei Chemicals Corporation Zellulosepartikel mit feinem kern und herstellungsverfahren dafür
US10137093B2 (en) 2011-08-16 2018-11-27 Cardiora Pty Ltd. Milrinone controlled-release formulation
MX2017008248A (es) 2014-12-22 2018-02-19 Cardiora Pty Ltd Metodo de tratamiento.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3328256A (en) * 1963-05-27 1967-06-27 William E Gaunt Spherical beads and their production
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
JPS50129727A (de) * 1974-04-04 1975-10-14
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IL61501A (en) * 1979-11-26 1984-06-29 Sterling Drug Inc 5-(pyridinyl)-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
US4313951A (en) * 1979-11-26 1982-02-02 Sterling Drug Inc. 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3126703A1 (de) * 1981-07-07 1983-01-27 Dr. Karl Thomae Gmbh, 7950 Biberach Bromhexin-retardform und verfahren zu ihrer herstellung
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
JPS58116414A (ja) * 1981-12-23 1983-07-11 Yamanouchi Pharmaceut Co Ltd ニカルジピン持続性製剤用球形顆粒およびその製造法
MX7567E (es) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd Procedimiento para recubrir nicardipina de accion prolongada
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale

Also Published As

Publication number Publication date
ZA854116B (en) 1986-01-29
EP0164959B1 (de) 1992-03-11
GB8414220D0 (en) 1984-07-11
DK164259C (da) 1992-10-19
ATE73323T1 (de) 1992-03-15
DK247285A (da) 1985-12-05
EP0164959A2 (de) 1985-12-18
FI87990C (fi) 1993-03-25
ES8608863A1 (es) 1986-07-16
AU4323685A (en) 1985-12-12
ES543826A0 (es) 1986-07-16
DK164259B (da) 1992-06-01
FI852235A0 (fi) 1985-06-04
DK247285D0 (da) 1985-06-03
PT80583B (pt) 1987-09-18
NO852225L (no) 1985-12-05
US4806361A (en) 1989-02-21
AU573006B2 (en) 1988-05-26
FI87990B (fi) 1992-12-15
NZ212268A (en) 1988-10-28
PT80583A (en) 1985-07-01
CA1258232A (en) 1989-08-08
NO166063B (no) 1991-02-18
IL75403A (en) 1988-08-31
KR860000068A (ko) 1986-01-25
FI852235L (fi) 1985-12-05
NO166063C (no) 1991-05-29
EP0164959A3 (en) 1986-12-17
DE3585560D1 (de) 1992-04-16
JPS611614A (ja) 1986-01-07
GR851356B (de) 1985-11-25
MX159928A (es) 1989-10-06
KR920004094B1 (ko) 1992-05-25

Similar Documents

Publication Publication Date Title
GB8414220D0 (en) Medicaments in unit dose form
IE812232L (en) Composition
AU578474B2 (en) Pharmaceutical composition of sparingly soluble medicaments for oral administration
EP0225189A3 (en) Targeted enteral delivery system
CA2282082A1 (fr) Microgranules contenant du cisplatine
GR3001238T3 (en) Process for the preparation of an administration and dosage for drugs, reagents or other active substances
CA2065809A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
EP0023359A3 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
DE69008107T2 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
GB9420748D0 (en) 1,5 benzodiazepine derivatives
DE3380294D1 (en) Pharmaceutical compositions in oral dosage form
JPS54126722A (en) Slow release antibiotic tablet
Baba et al. Clinical evaluation of clindamycin-2-phosphate in the treatment of various otorhinolaryngological infections--a multi-center study using an identical protocol
GR3002665T3 (en) Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
TH61079A (th) ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน